International Journal of Medical and Health Research

Authors
Bharat Kumar Shukla, Mohammed Saleem Khan, Taher Sadriwala

Abstract
Almost 80% of clinical trials fail to meet their patient enrollment quotas on time, causing delays in bringing new drugs to market and costing the biopharmaceutical industry increased in revenue for each day a drug is delayed. Customary patient enrollment techniques are deficient and don't scale to achieve the whole masses. What's more, in spite of the fact that web-based methods may hold promise for the future, today's aggressive market for clinical trial members requires another approach. Just 7% to 9% of the overall population has ever taken an interest in a clinical trial. By far most of eligible hopefuls are either uninformed of accessible trials or have a poor impression of clinical research. Opportunely, the development of electronic health data is making ready for a more proficient, versatile strategy to enroll patients for clinical trials. Data driven patient enrollment can empower more prominent reach and productivity, lessen trial deferrals and spare significant assets. Furthermore, it's inside our grip. Inventive organizations are as of now dialing-in data to expand the speed, number and nature of patients enlisted for clinical trials. With the proceeded with development of electronic health data, and arrangements for interconnected healthcare records frameworks not too far off, potential outcomes could drastically increase for clinical research. As an industry, we must collaborate on a greater scale to realize the full potential that data holds for patient recruitment. We should work with government, technology companies, patients, payers and healthcare providers to energize the dependable utilization of electronic healthcare data to progress clinical research and serve tomorrow's patients